Modern science versus the stigma of obesity

Nature Medicine

Volumn 10, Issue 6, 2004, Pages 563-569

  Friedman, Jeffrey M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; CANNABINOID; FENFLURAMINE; LEPTIN; NORADRENALIN UPTAKE INHIBITOR; PHENTERMINE; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE;

ANOREXIA; BODY WEIGHT; CLINICAL RESEARCH; DIET RESTRICTION; ENERGY EXPENDITURE; EXERCISE; GENETICS; HUMAN; MORBID OBESITY; OBESITY; PRIORITY JOURNAL; REVIEW; SOCIAL BEHAVIOR; VICTIM; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; BRAIN; EATING; ENERGY METABOLISM; HUMANS; LEPTIN; OBESITY;

EID: 2942716780     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0604-563     Document Type: Review

References (78)

1. Bray, G.A. Obesity: Historical development of scientific and cultural ideas. Int. J. Obes. 14, 909-926 (1990).
2. Buchwald, H. & Knatterud, M.E. Morbid obesity: perceptions of character and comorbidities in Falstaff. Obes. Surg. 10, 402-408 (2000).
3. Allison, D. et al. The heritability of body mass index among an international sample of monozygotic twins reared apart. Int. J. Obes. Relat. Metab. Disord. 20, 501-506 (1996).
4. Stunkard, A.J., Harris, J.R., Pedersen, N.L. & McClearn, G.E. The body-mass index of twins who have been reared apart. N. Engl. J. Med. 322, 1483-1487 (1990).
5. Stunkard, A.J., Foch, T.T. & Hrubec, Z. A twin study of human obesity. J. Am. Med. Assoc. 256, 51-54 (1986).
6. Friedman, J.M. A war on obesity, not the obese. Science 299, 856-858 (2003).
7. Flier, J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116, 337-350 (2004).
8. O'Rahilly, S., Farooqi, I.S., Yeo, G. & Challis, B.G. Minireview: Human obesity-lessons from monogenic disorders. Endocrinology 144, 3757-3764 (2003).
9. Leibel, R.L., Rosenbaum, M. & Hirsch, J. Changes in energy expenditure resulting from altered body weight. N. Engl. J. Med. 332, 621-628 (1995).
10. Wadden, T.A. et al. Short- and long-term changes in serum leptin dieting obese women: effects of caloric restriction and weight loss. J. Clin. Endocrinol. Metab. 83, 214-218 (1998).
11. Wadden, T.A. Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials. Ann. Intern. Med. 119, 688-693 (1993).
12. Farooqi, I. et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341, 879-884 (1999).
13. Farooqi, I.S. et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110, 1093-1103 (2002).
14. Flegal, K.M., Carroll, M.D., Ogden, C.L. & Johnson, C.L. Prevalence and trends in obesity among US adults, 1999-2000. J. Am. Med. Assoc. 288, 1723-1727 (2002).
15. Harris, T. et al. Body mass index and mortality among nonsmoking older persons: the Framingham Heart Study. J. Am. Med. Assoc. 259, 1520-1524 (1988).
16. Kopelman, P.G. Obesity as a medical problem. Nature 404, 635-643 (2000).
17. Hetherington, A.W. & Ranson, S.W. The spontaneous activity and food intake of rats with hypothalamic lesions. Am. J. Physiol. 136, 609-617 (1942).
18. Kandel, E.R., Schwartz, J.H. & Jessell, T. Principles of Neural Science, 998-1003 (McGraw-Hill, New York, 2000).
19. Friedman, J.M. & Halaas, J.L. Leptin and the regulation of body weight in mammals. Nature 395, 763-770 (1998).
20. Montague, C.T. et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903-908 (1997).
21. Farooqi, I. et al. Partial leptin deficiency and human adiposity. Nature 414, 34-35 (2001).
22. Maffei, M. et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155-1161 (1995).
23. Ahima, R.S. et al. Role of leptin in the neuroendocrine response to fasting. Nature 382, 250-252 (1996).
24. Shimomura, I., Hammer, R., Ikemoto, S., Brown, M. & Goldstein, J. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401, 73-76 (1999).
25. Oral, E.A. et al. Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 346, 570-578 (2002).
26. Oral, E.A. et al. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. J. Clin. Endocrinol. Metab. 87, 3110-3117 (2002).
27. Petersen, K.F. et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J. Clin. Invest. 109, 1345-1350 (2002).
28. Heymsfield, S. et al. Recombinant leptin for weight loss in obese and lean adults. J. Am. Med. Assoc. 282, 1568-1575 (1999).
29. Halaas, J.L. et al. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. USA 94, 8878-8883 (1997).
30. Minokoshi, Y. et al. Leptin stimulates fatty acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343 (2002).
31. Fei, H. et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc. Natl. Acad. Sci. USA 94, 7001-7005 (1997).
32. Glazer, G. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety. Arch. Intern. Med. 161, 1814-1824 (2001).
33. Heisler, L.K. et al. Activation of central melanocortin pathways by fenfluramine. Science 297, 609-611 (2002).
34. Seeley, R.J. et al. Melanocortin receptors in leptin effects. Nature 390, 349 (1997).
35. Erickson, J.C., Clegg, K.E. & Palmiter, R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381, 415-418 (1996).
36. Obici, S. & Rossetti, L. Minireview: Nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 144, 5172-5178 (2003).
37. Niswender, K.D. et al. Key enzymes in leptin-induced anorexia. Nature 413, 794-795 (2001).
38. Li, C. & Friedman, J. Leptin receptor activation of SH2 domain protein tyrosone phosphatase 2 modulates ob receptor signal transduction. Proc. Natl. Acad. Sci. USA 96, 9677-9682 (1999).
39. Zhao, A.Z., Huan, J.N., Gupta, S.K., Pal, R. & Sahu, A. A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding. Nat. Neurosci. 5, 727-728 (2002).
40. Vaisse, C. et al. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 14, 95-97 (1996).
41. Bates, S.H. et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421, 856-859 (2003).
42. Zabolothy, J.M. et al. PTP1B regulates leptin signal transduction in vivo. Dev. Cell 2, 489-495 (2002).
43. Bjorbaek, C., Elmquist, J.K., Frantz, J.D., Shoelson, S.E. & Flier, J.S. Identification of SOC-3 as a potential mediator of central leptin resistance. Mol. Cell 1, 619-625 (1998).
44. Yeo, G. et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20, 111-112 (1998).
45. Pinto, S. et al. Rapid re-wiring of arcuate nucleus feeding circuits by leptin. Science 304, 110-115 (2004).
46. West, D.B., Boozer, C.N., Moody, D.L. & Atkinson, R.L. Dietary obesity in nine inbred mouse strains. Am. J. Physiol. 262, R1025-R1032 (1992).
47. Ogus, S., Ke, Y., Qiu, J., Wang, B. & Chehab, F.F. Hyperleptinemia precipitates diet-induced obesity in transgenic mice overexpressing leptin. Endocrinology 144, 2865-2869 (2003).
48. Fulton, S., Woodside, B. & Shizgal, P. Modulation of brain reward circuitry by leptin. Science 287, 125-128 (2000).
49. Saper, C.B., Chou, T.C. & Elmquist, J.K. The need to feed: homeostatic and hedonic control of eating. Neuron 36, 199-211 (2002).
50. DeFalco, J. et al. Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science 291, 2608-2613 (2001).
51. Schwartz, M.W., Peskind, E., Raskind, M., Boyko, E.J. & Porte, D. Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat. Med. 2, 589-593 (1996).
52. Caro, J.F. et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348, 159-161 (1996).
53. Banks, W.A. & Farrell, C.L. Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. J. Physiol. 285, E10-E15 (2003).
54. Pas and other db/db mice. J. Biol. Chem. 273, 10078-10082 (1998).
55. Weintraub, M., Hasday, J.D., Mushlin, A.I. & Lockwood, D.H. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Arch. Intern. Med. 144, 1143-1148 (1984).
56. Heal, D.J., Cheetham, S.C., Prow, M.R., Martin, K.F. & Buckett, W.R. A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents. Br. J. Pharmacol. 125, 301-308 (1998).
57. Tecott, L.H. et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374, 542-546 (1995).
58. Di Marzo, V. et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410, B22-825 (2001).
59. Lavoisier, A.L. & DeLaplace, P.S. Memoir on heat; Read to the Royal Academy of Sciences, 28 June 1783. Obes. Res. 2, 189-203 (1994).
60. Rubner, M. Die Quelle der thierischen Warme. Z. Biol. 30, 73-142 (1894).
61. Weigle, D.S. Appetite and the regulation of body composition. FASEB J. 8, 302-310 (1994).
62. Allison, D.B., Heshka, S., Sepulveda, D. & Heymsfield, S.B. Counting calories-caveat emptor. J. Am. Med. Assoc. 270, 1454-1456 (1993).
63. Ravussin, E. et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N. Engl. J. Med. 318, 467-472 (1988).
64. Bouchard, C. et al. The response to long-term overfeeding in identical twins. N. Engl. J. Med. 322, 1477-1482 (1990).
65. Levine, J.A., Eberhardt, N.L. & Jensen, M.D. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 283, 212-214 (1999).
66. Brolin, R.E. Bariatric surgery and long-term control of morbid obesity. J. Am. Med. Assoc. 288, 2793-2796 (2002).
67. Halaas, J.L. et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546 (1995).
68. Bultman, S.J., Michaud, E.J. & Woychik, R.P. Molecular characterization of the mouse agouti locus. Cell 71, 1195-1204 (1992).
69. Smith, S. et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking DGAT. Nat. Genet. 25, 87-90 (2000).
70. Cohen, P. et al. Role for stearoyl-CoA desaturase-1 in leptin mediated weight loss. Science 297, 240-243 (2002).
71. Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998).
72. Wang, Y.X. et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113, 159-170 (2003).
73. Bachman. E.S. et al. βAR signaling required for diet-induced thermogenesis and obesity resistance. Science 297, 843-845 (2002).
74. Jackson, R.S. et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16, 303-306 (1997).
75. Krude, H. et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19, 155-157 (1998).
76. Barsh, G.S., Farooqi, I.S. & O'Rahilly, S. Genetics of body-weight regulation. Nature 404, 644-651 (2000).
77. Neel, J.V. Diabetes mellitus: A "thrifty" genotype rendered detrimental by "progress"? Am. J. Hum. Genet. 14, 353-362 (1962).
78. Tuomilehto, J. et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344, 1343-1350 (2001).